GE HealthCare Technologies (Nasdaq:GEHC) - Cotización, noticias y análisis

Resumen de acción GEHC

GEHC fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	2/6
Past Performance	1/6
Financial Health	3/6
Dividends	0/6

Recompensas

Cotiza un 50.3% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 14.89%

Cotiza a buen valor en comparación con empresas similares e industria

Análisis de riesgos

Tiene un alto nivel de endeudamiento

Competidores de GE HealthCare Technologies Inc.

IDEXX Laboratories

NasdaqGS:IDXX

US$39.9b

ResMed

NYSE:RMD

US$31.8b

Edwards Lifesciences

NYSE:EW

US$51.7b

DexCom

NasdaqGS:DXCM

US$51.7b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for GE HealthCare Technologies
Historical stock prices
Current Share Price	US$81.11
52 Week High	US$94.50
52 Week Low	US$62.35
Beta	0
1 Month Change	-7.52%
3 Month Change	-1.16%
1 Year Change	6.86%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	35.18%

Noticias y actualizaciones recientes

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

May 02

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25

Recent updates

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

May 02

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

Apr 02

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

Mar 25

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Could Be 29% Above Their Intrinsic Value Estimate

Oct 23

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 44% Above Its Share Price

Jun 28

Some Confidence Is Lacking In GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) P/E

Apr 17

Rentabilidad de los accionistas

	GEHC	US Medical Equipment	Mercado US
7D	3.6%	0.2%	3.3%
1Y	6.9%	-1.9%	25.0%

Rentabilidad vs. Industria: GEHC superó a la industria US Medical Equipment, que obtuvo un rendimiento del -0.6% el año pasado.

Rentabilidad vs. Mercado: GEHC obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.

Volatilidad de los precios

Is GEHC's price volatile compared to industry and market?
GEHC volatility
GEHC Average Weekly Movement	5.3%
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.1%
10% most volatile stocks in US Market	16.5%
10% least volatile stocks in US Market	3.0%

Precio estable de las acciones: GEHC no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de GEHC (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2022	51,000	Pete Arduini	www.gehealthcare.com

GE HealthCare Technologies Inc. se dedica al desarrollo, fabricación y comercialización de productos, servicios y soluciones digitales complementarias utilizadas en el diagnóstico, tratamiento y seguimiento de pacientes en Estados Unidos, Canadá e internacionalmente. La empresa opera a través de cuatro segmentos: Imagen, Ultrasonidos, Soluciones de Atención al Paciente y Diagnóstico Farmacéutico. El segmento de Imagen ofrece imagen molecular, tomografía computarizada (TC), resonancia magnética (RM), terapia guiada por imagen, sistemas de rayos X y productos para la salud de la mujer.

Resumen de fundamentos de GE HealthCare Technologies Inc.

¿Cómo se comparan los beneficios e ingresos de GE HealthCare Technologies con su capitalización de mercado?
Estadísticas fundamentales de GEHC
Capitalización bursátil	US$37.17b
Beneficios(TTM)	US$1.57b
Ingresos (TTM)	US$19.50b

23.5x

Ratio precio-beneficio (PE)

1.9x

Ratio precio-ventas (PS)

¿Está GEHC sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de GEHC
Ingresos	US$19.50b
Coste de los ingresos	US$11.56b
Beneficio bruto	US$7.93b
Otros gastos	US$6.36b
Beneficios	US$1.57b

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	3.45
Margen bruto	40.69%
Margen de beneficio neto	8.07%
Ratio deuda/patrimonio	121.8%

¿Cómo se ha desempeñado GEHC a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

0.1%

Rentabilidad actual por dividendo

3%

Ratio de pagos

Resumen de acción GEHC

Recompensas

Análisis de riesgos

Competidores de GE HealthCare Technologies Inc.

NasdaqGS:IDXX

US$39.9b

NYSE:RMD

US$31.8b

NYSE:EW

US$51.7b

NasdaqGS:DXCM

US$51.7b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings: EPS and revenues miss analyst expectations

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Recent updates

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings: EPS and revenues miss analyst expectations

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies' Roar Higher Isn't Over Yet

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Price target increased by 7.6% to US$90.21

Full year 2023 earnings: EPS misses analyst expectations

Now 33% overvalued after recent price rise

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year of 2024

GE HealthCare Q4 Earnings: Growth Lagging The Market

GE HealthCare Technologies Inc. Receives 510(K) Clearance from the United States Food and Drug Administration for Novii™+ Wireless Patch Solution

GE HealthCare Technologies Inc. Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

GE HealthCare Technologies Inc. to Report Q4, 2023 Results on Feb 06, 2024

Why GE HealthCare May Be Up To 50% Undervalued

GE HealthCare Technologies Inc. (NasdaqGS:GEHC) entered into definitive agreement to acquire MIM Software Inc.

GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital

Upcoming dividend of US$0.03 per share at 0.2% yield

GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023

GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis

GE HealthCare Technologies Inc. Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

GE Healthcare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

GE HealthCare Technologies Inc. Announces to Showcase Some of the Latest Innovations Designed to Help Clinicians in the Treatment of Cardiovascular Disease At the 2023 Transcatheter Cardiovascular Therapeutics Conference

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Could Be 29% Above Their Intrinsic Value Estimate

GE HealthCare Technologies Inc. to Report Q3, 2023 Results on Oct 31, 2023

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward

Upcoming dividend of US$0.03 per share at 0.2% yield

GE HealthCare Launches Enhanced Venue Family Ultrasound Systems Featuring AI-Driven Caption Guidance

GE HealthCare Technologies Inc. Announces Cash Dividend for Third Quarter of 2023, Payable on November 15, 2023

GE HealthCare Introduces Vscan Air SL, Wireless Handheld Ultrasound Device for Rapid Assessments of Cardiac and Vascular Patients

GE HealthCare Technologies Inc. Receives FDA Clearance for Portrait Mobile, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

CEO of Pharmaceutical Diagnostics notifies of intention to sell stock

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations

Upcoming dividend of US$0.03 per share at 0.1% yield

GE HealthCare Technologies Inc. to Report Q2, 2023 Results on Jul 25, 2023

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 44% Above Its Share Price

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of Fiscal Year 2023, Payable on August 15, 2023

GE HealthCare Technologies Inc. Announces the First Patient Scanned in a Phase I Clinical Trial of a Fluorine-18 PET Radiopharmaceutical

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.95 billion.

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.95 billion.

GE HealthCare Releases Reimagining Better Health